Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma. Cancer Chemother Pharmacol. 2009 Jun; 64(1):161-7.